Development of efficient adeno-associated virus (AAV)-mediated gene delivery system with a phytoactive material for targeting human melanoma cells

John Hwan Lee, Yoojin Kim, Ye Eun Yoon, Yong Jin Kim, Seong Geun Oh, Jae-Hyung Jang, Eunmi Kim

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

We exploited the emerging potential of gene therapy strategies to design a powerful therapeutic system that combines two key components—AAV vector and [6]-gingerol. In this study, we created an AAV2 construct expressing the proapoptotic protein BIM, which uses HSPG as its primary receptor, to target HSPG-overexpressing melanoma cells. This combination treatment showed promising results in vitro, inducing apoptosis in human melanoma cells. This new platform technology will make a significant contribution to numerous therapeutic applications, most notably for melanoma, including overcoming resistance to conventional anticancer therapies.

Original languageEnglish
Pages (from-to)194-199
Number of pages6
JournalNew Biotechnology
Volume37
DOIs
Publication statusPublished - 2017 Jul 25

Fingerprint

Gene therapy
Gene Transfer Techniques
Heparan Sulfate Proteoglycans
Dependovirus
Cell death
Viruses
Melanoma
Genes
Proteins
Apoptosis
Therapeutics
Genetic Therapy
Technology
gingerol

All Science Journal Classification (ASJC) codes

  • Biotechnology
  • Bioengineering
  • Molecular Biology

Cite this

Lee, John Hwan ; Kim, Yoojin ; Yoon, Ye Eun ; Kim, Yong Jin ; Oh, Seong Geun ; Jang, Jae-Hyung ; Kim, Eunmi. / Development of efficient adeno-associated virus (AAV)-mediated gene delivery system with a phytoactive material for targeting human melanoma cells. In: New Biotechnology. 2017 ; Vol. 37. pp. 194-199.
@article{dfcd13c22e72403f9a7cd4deffedc43e,
title = "Development of efficient adeno-associated virus (AAV)-mediated gene delivery system with a phytoactive material for targeting human melanoma cells",
abstract = "We exploited the emerging potential of gene therapy strategies to design a powerful therapeutic system that combines two key components—AAV vector and [6]-gingerol. In this study, we created an AAV2 construct expressing the proapoptotic protein BIM, which uses HSPG as its primary receptor, to target HSPG-overexpressing melanoma cells. This combination treatment showed promising results in vitro, inducing apoptosis in human melanoma cells. This new platform technology will make a significant contribution to numerous therapeutic applications, most notably for melanoma, including overcoming resistance to conventional anticancer therapies.",
author = "Lee, {John Hwan} and Yoojin Kim and Yoon, {Ye Eun} and Kim, {Yong Jin} and Oh, {Seong Geun} and Jae-Hyung Jang and Eunmi Kim",
year = "2017",
month = "7",
day = "25",
doi = "10.1016/j.nbt.2017.02.001",
language = "English",
volume = "37",
pages = "194--199",
journal = "New Biotechnology",
issn = "1871-6784",
publisher = "Elsevier",

}

Development of efficient adeno-associated virus (AAV)-mediated gene delivery system with a phytoactive material for targeting human melanoma cells. / Lee, John Hwan; Kim, Yoojin; Yoon, Ye Eun; Kim, Yong Jin; Oh, Seong Geun; Jang, Jae-Hyung; Kim, Eunmi.

In: New Biotechnology, Vol. 37, 25.07.2017, p. 194-199.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Development of efficient adeno-associated virus (AAV)-mediated gene delivery system with a phytoactive material for targeting human melanoma cells

AU - Lee, John Hwan

AU - Kim, Yoojin

AU - Yoon, Ye Eun

AU - Kim, Yong Jin

AU - Oh, Seong Geun

AU - Jang, Jae-Hyung

AU - Kim, Eunmi

PY - 2017/7/25

Y1 - 2017/7/25

N2 - We exploited the emerging potential of gene therapy strategies to design a powerful therapeutic system that combines two key components—AAV vector and [6]-gingerol. In this study, we created an AAV2 construct expressing the proapoptotic protein BIM, which uses HSPG as its primary receptor, to target HSPG-overexpressing melanoma cells. This combination treatment showed promising results in vitro, inducing apoptosis in human melanoma cells. This new platform technology will make a significant contribution to numerous therapeutic applications, most notably for melanoma, including overcoming resistance to conventional anticancer therapies.

AB - We exploited the emerging potential of gene therapy strategies to design a powerful therapeutic system that combines two key components—AAV vector and [6]-gingerol. In this study, we created an AAV2 construct expressing the proapoptotic protein BIM, which uses HSPG as its primary receptor, to target HSPG-overexpressing melanoma cells. This combination treatment showed promising results in vitro, inducing apoptosis in human melanoma cells. This new platform technology will make a significant contribution to numerous therapeutic applications, most notably for melanoma, including overcoming resistance to conventional anticancer therapies.

UR - http://www.scopus.com/inward/record.url?scp=85015339492&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85015339492&partnerID=8YFLogxK

U2 - 10.1016/j.nbt.2017.02.001

DO - 10.1016/j.nbt.2017.02.001

M3 - Article

C2 - 28179151

AN - SCOPUS:85015339492

VL - 37

SP - 194

EP - 199

JO - New Biotechnology

JF - New Biotechnology

SN - 1871-6784

ER -